Conversely, the CD43hi/galectin-1+ population expressed heightened levels of CD38 (Figure 2A, bottom), linking CD38 expression to a population harboring high CD45 activity and CLL proliferative capacity.24 Here, PTPRC is linked to B-cell chronic lymphocytic leukemia.